Spelling suggestions: "subject:"bascular smooth muscle cells (VSMC)"" "subject:"ascular smooth muscle cells (VSMC)""
1 |
THERAPEUTIC MECHANISMS OF INTERLEUKIN-19 FOR VASCULAR PROLIFERATIVE DISEASESCuneo, Anthony January 2012 (has links)
Cardiovascular disease is the leading cause of mortality in the western world. The pro-inflammatory and pro-proliferative etiology of vascular proliferative diseases is well characterized, while much less is known about the mechanisms of anti-inflammatory and anti-proliferative processes. Interleukin-19 (IL-19) is a newly described member of the IL-10 family of anti-inflammatory interleukins, and our group was the first to discover IL-19 expression in activated, synthetic, but not quiescent, contractile human vascular smooth muscle cells (hVSMC). We also found that IL-19 is anti-inflammatory and anti-proliferative for hVSMC. IL-19 is able to reduce the abundance of COX-2, IL-1β, IL-8, and Cyclin D1 transcripts which contain AU-rich elements (ARE) in their 3'-untranslated regions (3'-UTR). IL-19 is able to reduce the abundance of HuR, a stabilizing RNA-binding protein, which we feel provides a mechanism for these effects. The overall goal of this study is to elucidate IL-19's anti-inflammatory and anti-proliferative mechanism(s) in hVSMC in the context of vascular proliferative diseases. This goal has directed our overall hypothesis: IL-19's anti-proliferative and anti-inflammatory effects in hVSMC are mediated, at least in part, by modulation of HuR abundance and translocation, resulting in decreased stability of mRNA transcripts. HuR functions through a translocation mechanism, and IL-19 is able to reduce HuR cytoplasmic abundance. IL-19 also reduces HuR phosphorylation, which is a pre-requisite for HuR translocation, possibly through a PKCα-dependent mechanism. The stability of ARE-containing transcripts is reduced with IL-19 treatment, and reducing HuR expression by siRNA has the same inhibitory effect. VSMC are important mediators in the initiation of atherosclerosis. Oxidized low-density lipoprotein (ox-LDL) is able to induce IL-19 expression in these cells. VSMC are known to express scavenger receptors that take up ox-LDL. IL-19 is able to reduce the uptake of ox-LDL and the abundance of ox-LDL induced LOX-1 and CX-CL16 scavenger receptors. Interestingly, these scavenger receptors also have ARE in their 3'-UTR. IL-19 is able to reduce ox-LDL induced HuR cytoplasmic abundance. HuR knockdown by siRNA reduces the uptake of ox-LDL by hVSMC. These data suggest that IL-19 reduced scavenger receptor abundance may be due to decreased total and cytoplasmic HuR abundance. IL-19 reduces the abundance of ox-LDL induced COX-2 expression. Taken together, these results demonstrate that IL-19 down-regulates vital steps in vascular proliferative disease processes through an HuR-dependent mechanism. / Molecular and Cellular Physiology
|
2 |
Modulation of Endothelin-1 and Insulin-like Growth Factor Type 1-induced Signaling by Curcumin in A-10 Vascular Smooth Muscle CellsKapakos, Georgia 08 1900 (has links)
Les maladies cardio-vasculaires (MCV), telles que l’hypertension et l’athérosclérose, s’accompagnent de modifications structurales et fonctionnelles au niveau vasculaire. Un fonctionnement aberrant de la migration, l’hypertrophie et la prolifération des cellules musculaires lisses vasculaires (CMLV) sont des évènements cellulaires à l’origine de ces changements. L’endothéline-1 (ET-1) contribue à la pathogénèse des anomalies vasculaires, notamment via l’activation des protéines MAPK et PI3-K/PKB, des composantes clés impliquées dans les voies prolifératives et de croissance cellulaires. Il a été suggéré que le stress oxydant jouerait un rôle intermédiaire dans les effets pathophysiologiques vasculaires de l’ET-1. En conséquence, une modulation de la signalisation induite par l’ET-1 peut servir comme éventuelle stratégie thérapeutique contre le développement des MCV. Il apparaît de nos jours un regain d’intérêt dans l’utilisation des agents phyto-chimiques pour traiter plusieurs maladies. La curcumine, constituant essentiel de l’épice curcuma, est dotée de plusieurs propriétés biologiques parmi lesquelles des propriétés anti-oxydantes, anti-prolifératrices et cardio-protectrices. Cependant, les mécanismes moléculaires de son effet cardio-protecteur demeurent obscurs. Dans cette optique, l’objectif de cette étude a été d’examiner l’efficacité de la curcumine à inhiber la signalisation induite par l’ET-1 dans les CMLV. La curcumine a inhibé la phosphorylation des protéines IGF-1R, PKB, c-Raf et ERK1/2, induite par l’ET-1 et l’IGF-1. De plus, la curcumine a inhibé l’expression du facteur de transcription Egr-1 induite par l’ET-1 et l’IGF-1, dans les CMLV. Ces résultats suggèrent que la capacité de la curcumine à atténuer ces voies de signalisation serait un mécanisme d’action potentiel de ses effets protecteurs au niveau cardiovasculaire. / Cardiovascular diseases (CVDs), including hypertension and atherosclerosis, are associated with vascular functional and structural changes. Some of the cellular events underlying these processes include aberrant vascular smooth muscle cell (VSMC) proliferation, hypertrophy and migration. Endothelin-1 (ET-1) has been implicated in the pathogenesis of vascular abnormalities through the hyperactivation of key components of growth promoting and proliferative signaling pathways, including MAPKs and PI3-K/PKB. Vascular oxidative stress has also been suggested to play an intermediary role in mediating ET-1-induced pathophysiological effects. Interference with ET-1-induced signaling may therefore serve as a potential therapeutic strategy against the progression of cardiovascular disorders. There is presently a surge of interest in the use of plant-derived phytochemicals for the treatment of various diseases. Curcumin, the main constituent of the spice turmeric, exhibits multiple biological properties, amongst them, antioxidant, anti-proliferative and cardioprotective properties. However, the molecular mechanisms of its cardiovascular protective action remain obscure. Therefore, in the present studies, we investigated the effectiveness of curcumin to inhibit ET-1-induced signaling events in VSMC. Curcumin inhibited ET-1-induced as well as IGF-1-induced phosphorylation of IGF-1R, PKB, c-Raf and ERK1/2, in VSMC. Furthermore, curcumin inhibited the expression of transcription factor early growth response-1 (Egr-1) induced by ET-1 and IGF-1, in VSMC. In summary, these results demonstrate that curcumin is a potent inhibitor of ET-1 and IGF-1-induced mitogenic and proliferative signaling events in VSMC, suggesting that the ability of curcumin to attenuate these effects may contribute as potential mechanism for its cardiovascular protective response.
|
3 |
Modulation of Endothelin-1 and Insulin-like Growth Factor Type 1-induced Signaling by Curcumin in A-10 Vascular Smooth Muscle CellsKapakos, Georgia 08 1900 (has links)
Les maladies cardio-vasculaires (MCV), telles que l’hypertension et l’athérosclérose, s’accompagnent de modifications structurales et fonctionnelles au niveau vasculaire. Un fonctionnement aberrant de la migration, l’hypertrophie et la prolifération des cellules musculaires lisses vasculaires (CMLV) sont des évènements cellulaires à l’origine de ces changements. L’endothéline-1 (ET-1) contribue à la pathogénèse des anomalies vasculaires, notamment via l’activation des protéines MAPK et PI3-K/PKB, des composantes clés impliquées dans les voies prolifératives et de croissance cellulaires. Il a été suggéré que le stress oxydant jouerait un rôle intermédiaire dans les effets pathophysiologiques vasculaires de l’ET-1. En conséquence, une modulation de la signalisation induite par l’ET-1 peut servir comme éventuelle stratégie thérapeutique contre le développement des MCV. Il apparaît de nos jours un regain d’intérêt dans l’utilisation des agents phyto-chimiques pour traiter plusieurs maladies. La curcumine, constituant essentiel de l’épice curcuma, est dotée de plusieurs propriétés biologiques parmi lesquelles des propriétés anti-oxydantes, anti-prolifératrices et cardio-protectrices. Cependant, les mécanismes moléculaires de son effet cardio-protecteur demeurent obscurs. Dans cette optique, l’objectif de cette étude a été d’examiner l’efficacité de la curcumine à inhiber la signalisation induite par l’ET-1 dans les CMLV. La curcumine a inhibé la phosphorylation des protéines IGF-1R, PKB, c-Raf et ERK1/2, induite par l’ET-1 et l’IGF-1. De plus, la curcumine a inhibé l’expression du facteur de transcription Egr-1 induite par l’ET-1 et l’IGF-1, dans les CMLV. Ces résultats suggèrent que la capacité de la curcumine à atténuer ces voies de signalisation serait un mécanisme d’action potentiel de ses effets protecteurs au niveau cardiovasculaire. / Cardiovascular diseases (CVDs), including hypertension and atherosclerosis, are associated with vascular functional and structural changes. Some of the cellular events underlying these processes include aberrant vascular smooth muscle cell (VSMC) proliferation, hypertrophy and migration. Endothelin-1 (ET-1) has been implicated in the pathogenesis of vascular abnormalities through the hyperactivation of key components of growth promoting and proliferative signaling pathways, including MAPKs and PI3-K/PKB. Vascular oxidative stress has also been suggested to play an intermediary role in mediating ET-1-induced pathophysiological effects. Interference with ET-1-induced signaling may therefore serve as a potential therapeutic strategy against the progression of cardiovascular disorders. There is presently a surge of interest in the use of plant-derived phytochemicals for the treatment of various diseases. Curcumin, the main constituent of the spice turmeric, exhibits multiple biological properties, amongst them, antioxidant, anti-proliferative and cardioprotective properties. However, the molecular mechanisms of its cardiovascular protective action remain obscure. Therefore, in the present studies, we investigated the effectiveness of curcumin to inhibit ET-1-induced signaling events in VSMC. Curcumin inhibited ET-1-induced as well as IGF-1-induced phosphorylation of IGF-1R, PKB, c-Raf and ERK1/2, in VSMC. Furthermore, curcumin inhibited the expression of transcription factor early growth response-1 (Egr-1) induced by ET-1 and IGF-1, in VSMC. In summary, these results demonstrate that curcumin is a potent inhibitor of ET-1 and IGF-1-induced mitogenic and proliferative signaling events in VSMC, suggesting that the ability of curcumin to attenuate these effects may contribute as potential mechanism for its cardiovascular protective response.
|
Page generated in 0.0478 seconds